5ZE3
Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state
Summary for 5ZE3
Entry DOI | 10.2210/pdb5ze3/pdb |
Descriptor | Lysyl oxidase homolog 2, CALCIUM ION, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total) |
Functional Keywords | oxidoreductase |
Biological source | Homo sapiens (Human) |
Cellular location | Secreted, extracellular space, extracellular matrix, basement membrane : Q9Y4K0 |
Total number of polymer chains | 2 |
Total formula weight | 103027.57 |
Authors | |
Primary citation | Zhang, X.,Wang, Q.,Wu, J.,Wang, J.,Shi, Y.,Liu, M. Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state. Proc. Natl. Acad. Sci. U.S.A., 115:3828-3833, 2018 Cited by PubMed Abstract: Lysyl oxidases (LOXs), a type of copper- and lysyl tyrosylquinone (LTQ) -dependent amine oxidase, catalyze the oxidative deamination of lysine residues of extracellular matrix (ECM) proteins such as elastins and collagens and generate aldehyde groups. The oxidative deamination of lysine represents the foundational step for the cross-linking of elastin and collagen and thus is crucial for ECM modeling. Despite their physiological significance, the structure of this important family of enzymes remains elusive. Here we report the crystal structure of human lysyl oxidase-like 2 (hLOXL2) at 2.4-Å resolution. Unexpectedly, the copper-binding site of hLOXL2 is occupied by zinc, which blocks LTQ generation and the enzymatic activity of hLOXL2 in our in vitro assay. Biochemical analysis confirms that copper loading robustly activates hLOXL2 and supports LTQ formation. Furthermore, the LTQ precursor residues in the structure are distanced by 16.6 Å, corroborating the notion that the present structure may represent a precursor state and that pronounced conformational rearrangements would be required for protein activation. The structure presented here establishes an important foundation for understanding the structure-function relationship of LOX proteins and will facilitate LOX-targeting drug discovery. PubMed: 29581294DOI: 10.1073/pnas.1720859115 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.4 Å) |
Structure validation
Download full validation report